MedPath
TGA Approval

ELREXFIO elranatamab 44 mg/1.1 mL solution for injection vial (408212)

408212

ELREXFIO elranatamab 44 mg/1.1 mL solution for injection vial

Pfizer Australia Pty Ltd

June 28, 2024

Medicine

Medicine

Active

Registered - Prescription

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/a14b2da536d2098f33a886680798a55e.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/01cbd48b77fa74e2242b0562e15691e6.pdf

Active Ingredients

elranatamab

© Copyright 2025. All Rights Reserved by MedPath
ELREXFIO elranatamab 44 mg/1.1 mL solution for injection vial (408212) - TGA 批准文号 | MedPath